v3.22.2
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenues $ 20,623 $ 24,834 $ 41,228 $ 48,125
Cost of goods sold 6,414 7,229 12,824 13,467
Gross profit 14,209 17,605 28,404 34,658
Operating Expenses:        
General and administrative 24,289 25,541 49,606 51,701
Research and development 4,082 3,183 8,530 6,059
Gain on acquisition contingency (1,990) (2,236) (10,493) (2,287)
Asset impairment and abandonments 996 2,206 1,935 4,382
Transaction and integration expenses 222 2,188 1,138 2,510
Total operating expenses 27,599 30,882 50,716 62,365
Operating loss (13,390) (13,277) (22,312) (27,707)
Other expense (income) - net        
Other expense (income) - net 22 (101) 49 (105)
Interest expense 252 0 504 0
Foreign exchange loss (gain) 1,056 (95) 1,409 450
Change in fair value of warrant liability (9,124) (2,523) (18,867) (2,523)
Total other (income) - net (7,794) (2,719) (16,905) (2,178)
(Loss) before income tax provision (5,596) (10,558) (5,407) (25,529)
Income tax provision 92 81 254 300
Net (loss) from operations (5,688) (10,639) (5,661) (25,829)
Discontinued Operations (Note 3)        
(Loss) from operations of discontinued operations 0 (6,316) 0 (6,316)
Income tax (benefit) 0 (763) 0 (763)
Net income (loss) from discontinued operations 0 (5,553) 0 (5,553)
Net loss (5,688) (16,192) (5,661) (31,382)
Net income applicable to noncontrolling interests 0 0 0 0
Net income (5,688) (16,192) (5,661) (31,382)
Other comprehensive income (loss)        
Unrealized foreign currency translation (gain) loss (313) 35 (422) (36)
Total other comprehensive (loss) $ (5,375) $ (16,227) $ (5,239) $ (31,346)
Net loss from operations per share - basic (in dollars per share) $ (0.86) $ (2.79) $ (0.92) $ (7.29)
Net income (loss) from discontinued operations per common share - basic (in dollars per share) 0 (1.46) 0 (1.57)
Net loss per share applicable to Surgalign Holdings, Inc.- basic (in dollars per share) (0.86) (4.25) (0.92) (8.86)
Net loss from operations per share - diluted (in dollars per share) (0.86) (2.79) (0.92) (7.29)
Net income (loss) from discontinued operations per common share - diluted (in dollars per share) 0 (1.46) 0 (1.57)
Net loss per share applicable to Surgalign Holdings, Inc.- diluted (in dollars per share) $ (0.86) $ (4.25) $ (0.92) $ (8.86)
Weighted average basic shares (in shares) 6,640,405 3,808,475 6,174,273 3,542,497
Weighted average diluted shares (in shares) 6,640,405 3,808,475 6,174,273 3,542,497

Source